PREPARE Act of 2025
- Sponsor
- Sen. Hickenlooper, John W. [D-CO]
- Committees
- Judiciary Committee (primary)
- Last action
- Dec 18, 2025
Bottom line
The bill creates an advisory commission to develop a comprehensive federal regulatory framework for cannabis, aiming to inform future legislative and executive actions.
What it actually does
This bill, the PREPARE Act of 2025, establishes a Commission on the Federal Regulation of Cannabis within the Department of Justice. The Commission is tasked with studying and proposing measures for a prompt and plausible pathway to federal cannabis regulation, modeled after alcohol regulation. It will address issues ranging from the impact of criminalization and financial access for cannabis businesses to research barriers, product safety, and revenue frameworks, with a final report due one year after enactment.
Proponents argue
Supporters argue that federal cannabis prohibition is outdated and harmful, leading to discriminatory practices and hindering research and economic development. They contend that establishing a commission is a necessary and proactive step to prepare the federal government for the inevitable end of prohibition, ensuring a well-considered and equitable transition to a regulated market that learns from state experiences and alcohol regulation.
Opponents contend
Critics might argue that establishing a commission merely delays meaningful action on cannabis reform, preferring direct legislative changes to federal law. Some may also express concerns about the potential for increased cannabis use or public health issues if federal legalization proceeds, regardless of a commission's recommendations, or question the composition of the commission as potentially biased towards legalization.
The bill is concise and clearly structured, making it accessible for an informed reader to evaluate its provisions within a reasonable timeframe.
Section 4(a)
Establishment of the Commission on the Federal Regulation of Cannabis
This provision mandates the Attorney General to establish a commission, to be known as the "Commission on the Federal Regulation of Cannabis," within 30 days of the bill's enactment. The primary purpose of this Commission is to study and recommend a feasible and timely approach to federal cannabis regulation.
Supporters argue
Supporters argue that creating a dedicated commission is a crucial first step to systematically address the complexities of federal cannabis reform, ensuring that all relevant aspects are thoroughly studied before major policy changes are enacted.
Critics contend
Some critics might argue that establishing another commission is an unnecessary bureaucratic step that delays direct legislative action on cannabis reform, preferring immediate descheduling or legalization measures.
Tradeoffs
The tradeoff involves balancing the desire for swift reform with the need for comprehensive, well-researched policy development. A commission ensures thoroughness but may be perceived as slow.
Section 4(b)
Duties of the Commission
This section outlines the extensive responsibilities of the Commission, including proposing measures to alleviate the impact of cannabis criminalization on minority, low-income, and veteran communities; improving financial access for cannabis businesses; facilitating research; ensuring consistent product safety and labeling; and developing efficient revenue frameworks. It also mandates public comment periods and witness hearings, including testimony from formerly incarcerated individuals and cannabis industry participants.
Section 4(c)
Commission Membership
This provision details the composition of the 29-member Commission, including appointees from congressional leadership, various federal agencies (e.g., DOJ, ATF, NHTSA, FDA, IRS, USDA, HHS, VA), and experts in areas such as substance abuse prevention, cannabis criminalization history, medical cannabis, hemp cultivation, and small business access for marginalized communities. It also includes representatives from state cannabis control commissions and trade organizations.
The bill defines "cannabis" by explicitly referencing the term "marihuana" as defined in section 102 of the Controlled Substances Act (21 U.S.C. 802).
Section 3(1)
Why it matters:This is standard legislative practice to ensure legal precision and consistency with existing federal statutes, even when the intent is to reform those statutes.
Case for: Supporters would argue that this precise legal definition ensures that the Commission's work is grounded in current federal law, providing a clear starting point for its recommendations on how to transition away from that framework.
Case against: No specific opposition is typically raised against this definitional clarity, as it is a technical legal point. However, some advocates for immediate reform might see it as a reminder of the continued federal classification they wish to abolish.
Estimated impact: Ensures the Commission's scope is legally aligned with the federal substance it is tasked to regulate, impacting the foundational understanding of its work.
This provision mandates that if, after initial appointments, there is a partisan imbalance among Commission members, congressional leaders of the political party with fewer members shall jointly name additional members to create partisan parity.
Section 4(e)
Why it matters:This is a procedural safeguard to ensure political balance, which is a common practice in establishing commissions to promote bipartisan cooperation and legitimacy.
Case for: Proponents would argue that ensuring partisan parity fosters a more balanced and credible commission, increasing the likelihood that its recommendations will be broadly accepted across the political spectrum.
Case against: Some might argue that mandating strict partisan parity could lead to appointments based on political affiliation rather than solely on expertise, potentially hindering the commission's effectiveness or leading to gridlock.
Estimated impact: Ensures political balance on the Commission, potentially influencing the nature and reception of its final recommendations.
The bill specifies mandatory participants for the public witness hearing, including not less than two unique individuals or entities representing single-state licensed cannabis operations, not less than two representing multi-state licensed operations, an individual federally convicted for a non-violent cannabis offense, and an individual state-convicted for a non-violent cannabis offense.
Section 4(b)(2)(B)
Why it matters:While detailed, these specific requirements ensure that the Commission hears directly from key affected parties, including those with direct experience in the regulated industry and those who have suffered under prohibition. It's a deliberate attempt to ensure diverse and relevant testimony.
Case for: Supporters would highlight that these specific mandates ensure the Commission gathers crucial firsthand perspectives from those directly involved in the cannabis industry and those most impacted by past prohibition, leading to more informed and equitable recommendations.
Case against: No specific opposition is typically raised against ensuring diverse testimony, though some might argue that such prescriptive requirements could limit the Commission's flexibility in selecting the most relevant witnesses.
Estimated impact: Ensures that the Commission's data gathering includes critical perspectives from industry operators and individuals directly harmed by cannabis prohibition, significantly shaping the qualitative input for its recommendations.